(Bloomberg) -- Hi, it’s Giles from Europe, and Jared from our U.S. health team. We’re going to talk about SoftBank.

We know, We know. Enough already with SoftBank. But bear with us. Because this time it’s not about Uber or WeWork —it’s about how Alzheimer’s and data mining might give us an insight into SoftBank’s investment strategy.

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access